{
  "id": "reverse-transcription-pcr",
  "title": "Reverse-transcription PCR",
  "lang": "en",
  "source_lang": "en",
  "summary": "Reverse-transcription PCR converts RNA into complementary DNA and amplifies selected sequences for detection, quantification, and molecular analysis.",
  "category": "science",
  "subcategory": "biology",
  "type": "concept",
  "aliases": [
    "RT-PCR",
    "reverse transcription polymerase chain reaction",
    "reverse transcriptase PCR"
  ],
  "generated_at": "2026-11-03",
  "model": "pro/gpt-6.1-sol",
  "url": "https://aiwiki.page/en/reverse-transcription-pcr/",
  "translations": {
    "zh-Hans": {
      "url": "https://aiwiki.page/zh/reverse-transcription-pcr/",
      "json": "https://aiwiki.page/zh/reverse-transcription-pcr.json"
    }
  },
  "sections": [
    {
      "heading": "",
      "text": "Reverse-transcription PCR (RT-PCR) is a laboratory method that combines the conversion of RNA into complementary DNA (cDNA) with the selective amplification of that DNA by the polymerase chain reaction (PCR). The conversion is performed by a reverse transcriptase, an enzyme that synthesizes DNA using RNA as a template. Because conventional PCR amplifies DNA rather than RNA, reverse transcription makes RNA sequences accessible to PCR-based analysis.\n\nRT-PCR is widely used to investigate gene expression, detect RNA viruses, characterize RNA processing, and prepare material for subsequent molecular analysis. Its targets include messenger RNA, ribosomal RNA, viral genomes, and other RNA molecules. Depending on the experimental format, the result may establish whether a particular sequence is present, estimate its abundance, or provide an amplified product for DNA sequencing.\n\nThe abbreviation requires care: RT-PCR means reverse-transcription PCR, not real-time PCR. Real-time PCR monitors amplification as it occurs and can be performed on DNA without a reverse-transcription step. When reverse transcription is combined with quantitative real-time PCR, the method is commonly called RT-qPCR. Endpoint RT-PCR, RT-qPCR, and reverse-transcription digital PCR share the RNA-to-DNA conversion step but differ in how amplification products are measured and interpreted."
    },
    {
      "heading": "Molecular basis and enzymatic components",
      "text": "RT-PCR links two distinct template-directed reactions. In the first, reverse transcriptase extends a short nucleic-acid primer paired with an RNA molecule, incorporating deoxyribonucleotides into a complementary DNA strand. In the second, a thermostable DNA polymerase amplifies a selected region of that cDNA through repeated cycles of strand separation, primer annealing, and DNA synthesis. Both reactions depend on complementary base pairing, but their enzymes, templates, and preferred reaction conditions differ.\n\nReverse transcriptases used in laboratory assays have historically been derived from retroviruses, especially avian myeloblastosis virus and Moloney murine leukemia virus. Many current reagents are engineered derivatives with altered thermostability, processivity, or RNase H activity. RNase H cleaves RNA within RNA–DNA hybrids. Reduced RNase H activity can help preserve the RNA template during synthesis of long cDNA molecules, although the usefulness of any particular enzyme depends on the target and reaction design. Reverse transcription commonly occurs at approximately 37–55 °C, while some engineered enzymes support higher temperatures. Elevated temperatures can reduce obstructive RNA secondary structure, provided the enzyme remains active and the primer remains suitably paired.\n\nThe reverse-transcription reaction requires a primer because DNA synthesis proceeds by extension from an existing 3′ hydroxyl group. It also requires the four deoxyribonucleoside triphosphates, a suitable buffer, and usually magnesium ions. The concentrations of magnesium and nucleotides influence enzyme activity and pairing specificity. Strong RNA secondary structures, chemical damage to the template, and inhibitory substances carried over from extraction can all reduce the number of cDNA molecules produced.\n\nAfter reverse transcription, PCR uses two sequence-specific primers that define the boundaries of the amplified fragment, or amplicon. Heating, typically near 95 °C, separates DNA strands. Cooling permits primers to anneal, and an extension stage allows polymerase to copy the template. The exact temperature profile depends on the enzyme, primer sequences, and amplicon. The first PCR extension can establish a complementary DNA strand from single-stranded cDNA; subsequent cycles amplify double-stranded products.\n\nUnder idealized conditions, the number of target molecules after \\(n\\) PCR cycles is\n\n\\[N_n=N_0(1+E)^n,\\]\n\nwhere \\(N_0\\) is the initial number of amplifiable DNA targets and \\(E\\) is amplification efficiency per cycle. At \\(E=1\\), the target doubles each cycle. Actual reactions eventually depart from exponential behavior as reagents become limiting and products accumulate. Crucially, \\(N_0\\) represents amplifiable cDNA, not necessarily the original RNA count. Reverse-transcription efficiency introduces an additional, often target-dependent relationship between the RNA entering the assay and the DNA measured by PCR."
    },
    {
      "heading": "RNA specimens, extraction, and cDNA priming",
      "text": "The biological meaning of an RT-PCR result begins with the specimen. RNA extracted from cultured cells, blood, tissue, respiratory material, plants, or environmental samples represents different biological populations and presents different analytical difficulties. A tissue sample may contain several cell types whose relative abundance changes between specimens. A measured increase in a transcript can therefore reflect either altered expression within cells or a change in cellular composition. Similarly, an environmental viral RNA measurement describes material recovered from a sampled matrix, rather than a direct count of infectious particles.\n\nRNA is vulnerable to degradation by ribonucleases, which are widespread in biological material and laboratory environments. Sample preservation and extraction therefore influence the population of molecules available for analysis. Common extraction approaches use chaotropic salts to disrupt cells and inactivate proteins, followed by purification on silica membranes or magnetic particles. Organic extraction is another established approach. Residual phenol, ethanol, salts, heme, and other matrix components can inhibit reverse transcription, PCR, or both. Purity measurements alone do not establish that an extract is free of inhibitors.\n\nRNA integrity is especially important when comparing assays that target different parts of a transcript. An intact RNA molecule can support amplification at many positions, whereas a fragmented molecule may retain only some target regions. Electrophoretic methods can assess RNA size distributions, and metrics such as the RNA integrity number summarize features of the electropherogram. These metrics are useful but not universally predictive: a short target may remain detectable in degraded material, and integrity measures based largely on ribosomal RNA do not directly describe every messenger RNA. Formalin fixation can introduce fragmentation and chemical modifications, making performance strongly dependent on amplicon length and target location.\n\nThree main priming strategies govern which molecules become cDNA. Oligo(dT) primers bind the poly(A) tails of most eukaryotic messenger RNAs. They enrich the reaction toward polyadenylated transcripts but may produce a 3′ bias when RNA is degraded or reverse transcription does not reach the transcript’s distant 5′ end. Random primers bind at many positions and can copy a broader RNA population, including abundant ribosomal RNA. Gene-specific primers concentrate reverse transcription on selected targets and are often used in targeted assays, but they restrict which sequences can subsequently be examined.\n\nResidual genomic DNA is another major concern. DNase treatment can reduce it, while primer placement can distinguish some transcript-derived products from genomic sequences. A primer spanning an exon–exon junction may recognize spliced cDNA without efficiently recognizing the corresponding genomic region. Primers placed in separate exons can produce a much larger genomic product if an intron lies between them. These designs depend on RNA splicing and gene architecture; they do not automatically solve contamination problems for intronless genes, processed pseudogenes, or closely related sequences."
    },
    {
      "heading": "Reaction formats and target design",
      "text": "In two-step RT-PCR, reverse transcription and PCR are separate reactions. A cDNA preparation is first made from the RNA sample, and portions are then transferred into one or more PCR assays. This format permits many targets to be examined from the same cDNA pool and allows reverse-transcription and PCR conditions to be optimized independently. It is particularly useful in expression studies involving multiple genes. Its disadvantages include additional handling, opportunities for contamination, and the need to account consistently for cDNA dilution and the fraction of each preparation entering PCR.\n\nIn one-step RT-PCR, reverse transcription and PCR occur sequentially in the same reaction vessel, usually with both enzyme activities present from the beginning. An initial incubation supports cDNA synthesis, followed by thermal cycling for amplification. One-step formats reduce transfers and are well suited to standardized, high-throughput testing of a defined target set. Reverse transcription is commonly driven by the target-specific PCR primers, although reagent systems differ. Conditions must accommodate both enzymatic stages, and the resulting preparation is less flexible than a separate cDNA pool for later testing of unrelated targets.\n\nPrimer design determines much of the assay’s specificity. Each primer must bind its intended sequence efficiently while avoiding strong self-complementarity, complementarity with the other primer, and substantial similarity to unintended templates. Primer dimers are short products generated when primers interact and become extended; they can consume reagents and produce misleading fluorescence in assays that detect all double-stranded DNA. Related genes, alternative splice forms, pseudogenes, and pathogen sequence variation must also be considered. A technically successful assay may measure several transcript forms together if its target region is shared among them.\n\nAmplicon length reflects the analytical purpose. RT-qPCR assays often use short products, commonly around 70–200 base pairs, because short targets generally amplify efficiently and are more likely to remain intact in fragmented RNA. Longer products can be useful for sequence characterization, cloning, or analysis across multiple splice junctions, but they place greater demands on RNA integrity and reverse-transcriptase processivity. A short amplicon demonstrates the presence of its local sequence; it does not demonstrate that an entire transcript or viral genome is intact.\n\nMultiplex RT-PCR detects several targets in one reaction by combining multiple primer pairs and, in fluorescence-based systems, distinguishable detection probes. This can conserve sample and include an internal control alongside the main targets. However, each additional assay creates possible interactions and competition for reagents. A highly abundant target can influence detection of a scarce one, so performance established in single-target reactions does not necessarily transfer unchanged to the multiplex format.\n\nNested RT-PCR uses a second amplification with primers located inside the first amplicon. It can increase analytical sensitivity and specificity, but transferring first-round products creates a substantial carryover-contamination risk. Strand-specific RT-PCR introduces a different design challenge: detecting the orientation of an RNA molecule requires control of unintended priming during reverse transcription. Tagged reverse-transcription primers can improve discrimination, but apparent strand specificity requires experimental validation rather than inference from primer orientation alone."
    },
    {
      "heading": "Endpoint, real-time, and digital detection",
      "text": "In endpoint RT-PCR, amplified products are examined after thermal cycling has finished. Gel electrophoresis separates DNA fragments by size and can show whether a band of the expected length is present. Sequencing or an additional sequence-specific detection method can provide stronger evidence of identity, because unrelated products can have similar lengths. Endpoint detection is well suited to confirming particular transcripts, examining splice products, and generating material for downstream work. It is generally less suitable for accurate quantification because the final product yield may lie in the reaction’s plateau phase, where it no longer preserves a simple relationship to starting abundance.\n\nReal-time PCR measures fluorescence during successive amplification cycles. In RT-qPCR, this follows the conversion of RNA to cDNA. One major detection approach uses dyes that fluoresce strongly when associated with double-stranded DNA. These dyes are relatively simple to use but report intended amplicons, nonspecific products, and primer dimers alike. A melting-curve analysis can help distinguish products by monitoring fluorescence as the DNA duplexes dissociate during heating. Nevertheless, a single melting peak is not definitive proof that the correct sequence was amplified.\n\nAnother approach uses sequence-specific fluorescent probes. In a hydrolysis-probe assay, a probe binds within the amplicon and carries a reporter fluorophore and a quencher. During extension, the polymerase’s nuclease activity cleaves a bound probe, separating reporter from quencher and increasing fluorescence. This provides an additional sequence-recognition event beyond the two primers and supports multiplexing with different fluorophores. Other probe formats use different molecular mechanisms, so not every probe-based assay depends on probe hydrolysis.\n\nReal-time instruments generate amplification curves from which software determines a quantification cycle, usually written \\(C_q\\); the term threshold cycle, or \\(C_t\\), is also widely used. This value describes the cycle position at which amplification reaches a defined measurement criterion. It is not a direct molecular count. Baseline correction, threshold placement, reaction efficiency, fluorescence chemistry, and instrument processing all influence the reported value. Consequently, an identical \\(C_q\\) on two different assays need not indicate an identical quantity of RNA.\n\nDigital PCR takes a different approach. The sample is divided among many small partitions, such as droplets or chambers, and amplification is assessed as positive or negative in each partition. Reverse transcription can occur before partitioning or within the partitioned reaction, depending on the platform. If targets are randomly distributed and partitions behave as assumed, the mean number of amplifiable targets per partition is estimated from the negative fraction \\(f_0\\):\n\n\\[\\lambda=-\\ln(f_0).\\]\n\nPartition volume and dilution then relate this occupancy to concentration. Digital counting avoids the need for a conventional calibration curve, but it still depends on reverse-transcription yield, partition properties, inhibition, and classification of positive and negative signals."
    },
    {
      "heading": "Quantification, calibration, and normalization",
      "text": "Quantitative RT-PCR can estimate RNA abundance either relative to another sample or against a calibration series. In absolute quantification, standards with assigned target quantities establish the relationship between starting amount and \\(C_q\\). Standards may be synthetic RNA, in vitro-transcribed RNA, purified DNA, or plasmid preparations, but these materials do not necessarily behave equivalently. DNA standards calibrate the PCR stage without testing reverse transcription. An RNA standard introduced before reverse transcription captures more of the analytical process, while a standard added before extraction may additionally reflect recovery from the sample matrix.\n\nA typical calibration relationship is\n\n\\[C_q=m\\log_{10}(N_0)+b,\\]\n\nwhere \\(m\\) is the slope and \\(b\\) the intercept. Under a constant-efficiency model,\n\n\\[E=10^{-1/m}-1.\\]\n\nA slope near \\(-3.32\\) corresponds to approximately 100% amplification efficiency: a tenfold increase in starting template shifts the result by about 3.32 cycles. This interpretation applies within the validated linear range. An apparently excellent straight line does not by itself establish that a standard has the correct assigned concentration or that clinical or biological samples amplify in the same way.\n\nRelative quantification compares a target across samples, commonly after normalization to one or more reference transcripts. If amplification efficiencies are sufficiently similar and close to doubling per cycle, a frequently used calculation is\n\n\\[\\Delta C_q=C_{q,\\mathrm{target}}-C_{q,\\mathrm{reference}},\\]\n\n\\[\\Delta\\Delta C_q=\\Delta C_{q,\\mathrm{sample}}-\\Delta C_{q,\\mathrm{calibrator}},\\]\n\nwith relative abundance expressed as\n\n\\[2^{-\\Delta\\Delta C_q}.\\]\n\nThis calculation is convenient, but its assumptions matter. Different amplification efficiencies require an efficiency-aware model. A reference transcript that changes with treatment, development, disease, or cell composition can distort the inferred target change even when the PCR measurements themselves are technically precise.\n\nCommon reference genes include GAPDH and ACTB, but neither is universally stable. Reference-gene suitability is an experimental property of the particular sample set. Using multiple independently assessed reference genes can reduce dependence on any single transcript. Normalization to total RNA input answers a different question from normalization to cell number, tissue mass, or a reference transcript. These denominators can diverge when cells differ in size, RNA content, or metabolic state. Thus, “expression level” is incomplete without specifying what the measurement is relative to.\n\nSeveral distinct performance characteristics must also be separated. The limit of detection describes the amount detectable with a stated probability, whereas the limit of quantification concerns an amount measurable with acceptable precision and other specified performance criteria. Neither is determined solely by the lowest observed positive reaction. Near the detection limit, the random allocation of scarce molecules produces variable outcomes, including negative replicates. Technical replication characterizes aspects of measurement variability, while independent biological replication addresses variation among biological units. More technical replicates cannot substitute for missing biological replication, and precise cDNA measurements do not eliminate uncertainty in the original RNA-to-cDNA conversion."
    },
    {
      "heading": "Controls, validation, and interpretation of results",
      "text": "Different controls interrogate different failure modes. A no-template control contains amplification reagents without sample nucleic acid and can reveal reagent contamination or nonspecific products. It does not test contamination introduced during extraction. An extraction blank accompanies specimens through extraction and subsequent analysis, helping reveal contamination acquired along that path. A no-reverse-transcriptase control omits the reverse-transcription enzyme and tests whether DNA already present in the RNA preparation can generate the observed signal. None of these controls substitutes for the others.\n\nPositive controls establish that the assay can detect an appropriate target under the conditions used. Their meaning depends on their composition and point of introduction. A DNA positive control tests amplification and detection but not RNA conversion. An RNA control tests reverse transcription as well, while a process control added before extraction can also provide information about extraction performance. An endogenous control, such as a host transcript expected in the specimen, can help assess sample content and processing, but its abundance may vary biologically. An exogenous control offers a defined input yet may not mimic the extraction behavior or stability of the native target.\n\nContamination is especially consequential because PCR can amplify minute amounts of previous amplification products. Physical separation of pre-amplification and post-amplification activities, unidirectional sample movement, closed-tube detection, and controlled reagent handling reduce this risk. Some systems incorporate deoxyuridine triphosphate into products and use uracil-DNA glycosylase to damage uracil-containing carryover products before amplification. The strategy must be compatible with the full reverse-transcription and PCR chemistry. It does not eliminate contamination by every possible source, particularly target molecules that do not contain uracil in DNA.\n\nValidation distinguishes analytical specificity from analytical sensitivity. Specificity includes both avoiding cross-reactions with unintended sequences and retaining recognition of relevant target variants. A mutation in a primer- or probe-binding region can weaken detection, sometimes causing one component of a multitarget assay to fail while others remain positive. Sensitivity depends on the entire process, including specimen volume, extraction recovery, elution volume, RNA stability, reverse-transcription yield, and the amount placed in each reaction. A sensitivity claim for purified reference RNA is therefore not automatically a sensitivity claim for every specimen type.\n\nIn diagnostic applications, analytical performance is also distinct from clinical performance. A negative result can reflect absence of the target, insufficient target in the sampled material, degradation, inhibition, or sampling outside the period of detectability. A positive result establishes detection of the defined nucleic-acid sequence under the assay’s interpretation rules. It does not necessarily establish active replication, infectiousness, or the biological cause of a patient’s condition. In particular, an RT-qPCR cycle value is not a universally transferable measure of viral load or infectiousness.\n\nTransparent reporting makes these distinctions assessable. The MIQE guidelines, published in 2009 as the Minimum Information for Publication of Quantitative Real-Time PCR Experiments, specify information needed to evaluate qPCR experiments, including sample handling, assay characteristics, controls, and analysis. For RT-qPCR, documenting the reverse-transcription stage is essential: apparently identical PCR assays can produce different results when cDNA synthesis differs."
    },
    {
      "heading": "Biological, clinical, and environmental applications",
      "text": "One of RT-PCR’s central research applications is targeted analysis of gene expression. Investigators use it to compare selected transcripts across cell types, developmental stages, experimental treatments, and disease-associated specimens. Because the assay measures RNA rather than protein, its result concerns transcript abundance, not necessarily protein concentration or activity. Translation efficiency and protein turnover can separate RNA changes from changes in functional protein. RT-qPCR is also used to examine selected observations from broader transcriptomic experiments, although agreement between methods depends on whether both methods measure the same transcript regions and variants.\n\nTranscript structure is another major application. Primers positioned across exons can reveal exon inclusion, exon skipping, or other splice patterns, while sequencing the amplified product can identify the junction involved. Such assays help investigate alternative splicing and gene fusions. A fusion-transcript assay, for example, may place primers in sequences contributed by different genes so that amplification depends on their joining in a single RNA molecule. The BCR::ABL1 fusion transcript is an established target in molecular testing and monitoring of chronic myeloid leukemia. Standardized reporting in this setting requires more than a raw \\(C_q\\): control-gene measurements and alignment with an established measurement scale are important.\n\nRT-PCR is fundamental to laboratory detection of many RNA viruses, including influenza viruses, human immunodeficiency virus, hepatitis C virus, and SARS-CoV-2. Depending on the validated assay, the objective may be qualitative detection, quantitative monitoring, or identification of selected sequence features. During the COVID-19 pandemic beginning in 2020, RT-qPCR became a central method for detecting SARS-CoV-2 RNA. Multitarget designs provided redundancy by examining more than one region of the viral genome, while sequencing remained necessary for comprehensive characterization of viral variants.\n\nEnvironmental applications include detection of viral RNA in wastewater, surface water, food, and other complex materials. Wastewater surveillance can reveal changes in the amount of target RNA entering a sewer catchment and can complement other forms of public-health surveillance. Interpretation is affected by sampling design, wastewater flow, population contributions, decay, and the concentration and extraction methods used. A concentration measured in wastewater is not directly equivalent to a count of infected individuals. Inhibition and variable recovery are particularly important in these heterogeneous matrices.\n\nReverse transcription also underlies workflows that extend beyond conventional targeted RT-PCR. Many RNA sequencing methods convert RNA into cDNA before library amplification and sequencing. Single-cell methods can combine cDNA synthesis, molecular barcoding, and amplification to characterize transcripts from individual cells. These are not simply interchangeable names for RT-PCR, but they share important enzymatic constraints, including incomplete conversion and sequence-dependent bias. Targeted RT-PCR remains distinct in that predefined primers select particular sequences, giving high sensitivity for known targets while providing little information about unanticipated sequences outside the assay design."
    },
    {
      "heading": "Historical development and methodological boundaries",
      "text": "The discovery of reverse transcriptase preceded PCR. In 1970, Howard Temin and Satoshi Mizutani, and independently David Baltimore, reported RNA-dependent DNA polymerase activity in tumor viruses. These findings established an enzymatic route from RNA to DNA and helped explain the replication of retroviruses. The discovery had wider significance for molecular biology because it demonstrated that genetic information could be copied from RNA into DNA. Reverse transcriptases subsequently became practical tools for synthesizing cDNA from cellular and viral RNA.\n\nPCR emerged in the 1980s through work associated with Kary Mullis and colleagues at Cetus. Early methods required repeated additions of enzyme because heating destroyed the polymerase; thermostable polymerases subsequently made thermal cycling more practical and efficient. PCR’s capacity to amplify selected DNA sequences created an immediate complement to cDNA synthesis. Combining the two processes enabled scarce RNA targets to be studied through a much larger population of DNA copies, avoiding the need to detect the original RNA directly.\n\nDuring the late 1980s and 1990s, RT-PCR became established in gene-expression research and molecular diagnostics. Early assays commonly used endpoint gels, sometimes with additional hybridization to confirm product identity. Competitive approaches attempted quantification by amplifying a target alongside a related internal standard. The development of fluorescence-based real-time amplification in the 1990s shifted quantitative analysis toward measurements made during the exponential phase rather than after the reaction reached its endpoint. Hydrolysis probes, double-stranded-DNA dyes, and improved instruments supported increasingly automated analysis.\n\nA prominent development in relative expression analysis was the 2001 description by Kenneth Livak and Thomas Schmittgen of the \\(2^{-\\Delta\\Delta C_T}\\) method. Its widespread adoption simplified comparison of many experimental samples but also made the importance of reference-gene stability and amplification-efficiency assumptions more visible. The 2009 MIQE guidelines addressed broader problems of incomplete reporting and reproducibility. Later developments in digital PCR, automated extraction, multiplex chemistry, and integrated instruments expanded the available measurement formats without removing the need to validate reverse transcription itself.\n\nRT-PCR is related to, but distinct from, several neighboring technologies. Direct RNA detection by Northern blotting can provide information about transcript size without enzymatic target amplification, although it generally requires more starting material. Reverse-transcription loop-mediated isothermal amplification also converts RNA into an amplifiable target but uses a different amplification mechanism operating at a largely constant temperature rather than PCR thermal cycling. Direct RNA sequencing can read RNA without first making cDNA, whereas many other sequencing workflows retain a reverse-transcription stage.\n\nThese distinctions define what an RT-PCR measurement can establish. It is a targeted analysis of sequences represented in a cDNA preparation, with specificity imposed by primers and sometimes probes. Its extraordinary sensitivity results from enzymatic amplification, not from complete recovery or faithful counting of every original RNA molecule. Changes in extraction, priming, target location, calibration material, or detection platform can therefore alter the relationship between a biological specimen and the reported result, even when every method is described broadly as RT-PCR."
    }
  ],
  "links": [
    "rna",
    "complementary-dna",
    "polymerase-chain-reaction",
    "reverse-transcriptase",
    "gene-expression",
    "virus",
    "messenger-rna",
    "ribosomal-rna",
    "dna-sequencing",
    "dna-polymerase",
    "molar-concentration",
    "cell",
    "dna",
    "rna-splicing",
    "alternative-splicing",
    "gel-electrophoresis",
    "quantitative-pcr",
    "digital-pcr",
    "plasmid",
    "mutation",
    "protein",
    "public-health",
    "rna-sequencing"
  ],
  "sources": [],
  "license": "https://creativecommons.org/licenses/by/4.0/"
}